U.S. Physical Therapy (USPH) to Release Quarterly Earnings on Wednesday

U.S. Physical Therapy (NYSE:USPH) is projected to announce its Q2 2026 results after the market closes on Wednesday, August 5th. Analysts expect the company to post earnings of $0.85 per share and revenue of $211.36 million for the quarter. Individuals can find conference call details on the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Thursday, August 6, 2026 at 10:30 AM ET.

U.S. Physical Therapy (NYSE:USPH) last posted its earnings results on Wednesday, May 6th. The company reported $0.46 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.55 by ($0.09). U.S. Physical Therapy had a return on equity of 8.81% and a net margin of 4.36%.The firm had revenue of $198.29 million during the quarter, compared to analysts’ expectations of $200.94 million. During the same quarter in the prior year, the company earned $0.48 earnings per share. The business’s revenue for the quarter was up 7.9% compared to the same quarter last year. On average, analysts expect U.S. Physical Therapy to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

U.S. Physical Therapy Stock Up 0.3%

Shares of NYSE:USPH opened at $79.31 on Monday. The firm has a fifty day moving average price of $68.76 and a two-hundred day moving average price of $74.46. The company has a market cap of $1.21 billion, a price-to-earnings ratio of 158.62, a PEG ratio of 2.19 and a beta of 1.13. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.19 and a quick ratio of 1.19. U.S. Physical Therapy has a one year low of $58.19 and a one year high of $93.50.

U.S. Physical Therapy Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, June 12th. Investors of record on Friday, May 22nd were given a $0.46 dividend. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date was Friday, May 22nd. U.S. Physical Therapy’s dividend payout ratio (DPR) is 368.00%.

Insider Buying and Selling

In other U.S. Physical Therapy news, Director Peter Francis Minan purchased 492 shares of the firm’s stock in a transaction on Monday, June 8th. The shares were purchased at an average cost of $63.14 per share, with a total value of $31,064.88. Following the completion of the purchase, the director owned 2,923 shares of the company’s stock, valued at $184,558.22. The trade was a 20.24% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 2.40% of the stock is owned by insiders.

Hedge Funds Weigh In On U.S. Physical Therapy

Institutional investors and hedge funds have recently made changes to their positions in the business. Advisory Services Network LLC bought a new stake in U.S. Physical Therapy in the third quarter worth $39,000. iSAM Funds UK Ltd bought a new position in shares of U.S. Physical Therapy during the third quarter valued at about $52,000. Aquatic Capital Management LLC grew its stake in shares of U.S. Physical Therapy by 445.4% during the third quarter. Aquatic Capital Management LLC now owns 1,369 shares of the company’s stock valued at $116,000 after buying an additional 1,118 shares during the last quarter. Vestcor Inc bought a new position in shares of U.S. Physical Therapy during the third quarter valued at about $117,000. Finally, State of Wyoming increased its holdings in shares of U.S. Physical Therapy by 85.3% in the second quarter. State of Wyoming now owns 1,575 shares of the company’s stock worth $123,000 after buying an additional 725 shares during the period.

Analysts Set New Price Targets

USPH has been the subject of several research analyst reports. Zacks Research raised U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research note on Wednesday, May 27th. Barrington Research decreased their target price on U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 13th. Citigroup reaffirmed a “market outperform” rating on shares of U.S. Physical Therapy in a report on Friday, July 24th. Weiss Ratings reiterated a “hold (c-)” rating on shares of U.S. Physical Therapy in a research report on Friday, May 29th. Finally, Citizens Jmp reiterated a “market outperform” rating and set a $98.00 price target on shares of U.S. Physical Therapy in a research report on Wednesday, June 24th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, U.S. Physical Therapy has an average rating of “Moderate Buy” and an average price target of $97.50.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.